| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.41 | 0.01 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |